Intended for healthcare professionals

Rapid response to:

Feature BMJ Investigation

Covid-19: Researcher blows the whistle on data integrity issues in Pfizer’s vaccine trial

BMJ 2021; 375 doi: https://doi.org/10.1136/bmj.n2635 (Published 02 November 2021) Cite this as: BMJ 2021;375:n2635

Read our latest coverage of the coronavirus pandemic

Rapid Response:

Re: Covid-19: Researcher blows the whistle on data integrity issues in Pfizer’s vaccine trial

Dear Editor

I am grateful to Thomas Finnegan [1] for pointing out my error and the Pfizer trial had in fact included British participants. I am also pleased to know of his FOI requests to the MHRA, but he will perhaps be concerned to learn that the MHRA has failed to publish a single FOI response since the end of June [2]. I have been in touch with them about this. Perhaps hundreds remain unpublished.

I am also concerned that that the MHRA licensed the trials for the Oxford/AZ product which included adenoviruses associated with blood clots and subsequently approved it as well as the similar Johnson & Johnson for roll-out [3,4]

[1] Thomas Finnegan, ‘ Re: Covid-19: Researcher blows the whistle on data integrity issues in Pfizer’s vaccine trial’, 24 November 2021, https://www.bmj.com/content/375/bmj.n2635/rr-60

[2] https://www.gov.uk/government/collections/freedom-of-information-respons...

[3] John Stone, ‘Re: Covid-19: Rare immune response may clause clots after AstraZeneca vaccine, say researchers’, 16 April 2021, https://www.bmj.com/content/373/bmj.n954/rr-2

[4] John Stone, ‘Had the MHRA done due diligence’, 21 April 2021, https://www.bmj.com/content/373/bmj.n961/rr-0

Competing interests: AgeofAutism.com, an on-line daily journal, concerns itself with the potential environmental sources for the proliferation of autism, neurological impairment, immune dysfunction and chronic disease. I receive no payment as UK Editor. I also moderate comments for the on-line journal ‘The Defender’ for which I am paid. I am also a member of the UK Medical Freedom Alliance

25 November 2021
John Stone
UK Editor
AgeofAutism.com
London N22